🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the potential drug interactions between vemirco...
Status
Completed
Location
Research Site
Start Date
2024-01-17
Trial ID
NCT06071442
Treatments Being Tested
The purpose of this study is to evaluate the effect of JNJ-64530440 single-...
Status
Withdrawn
Location
PRA Health Sciences
Start Date
2021-06-01
Trial ID
NCT03890341
Treatments Being Tested
The objectives of this study were to evaluate the efficacy and safety of dr...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00656981
Treatments Being Tested
This is a Phase 1, fixed sequence, multiple dose, open label study of the e...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2019-10-23
Trial ID
NCT04134715
Treatments Being Tested
The purpose of the study is to determine the bioequivalence of Norgestimate...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00709644
Treatments Being Tested
The objectives of this study were to evaluate the efficacy and safety of dr...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00651469
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2019-08-09
Trial ID
NCT04018274
Treatments Being Tested
This is a Phase 1, open label, fixed sequence study of the effect of multip...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2021-10-08
Trial ID
NCT05064332
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of a low do...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01236768
This is a Phase 1, randomized, 2 way crossover, multiple dose, open label s...
Status
Completed
Location
Quotient Sciences
Start Date
2018-09-21
Trial ID
NCT03608241
Treatments Being Tested